Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Herald-Tribune: Generic drug costs could rise under new tariff plan
“Imposing massive tariffs on generic medicines risks making lower-cost generic drugs millions of Americans rely on more expensive and harder to access,” said Merith Basey, CEO of Patients for Affordable Drugs. “Tariffs of this magnitude could have enormous consequences − raising costs, worsening shortages and putting access to lifesaving medicines at risk.”
News and Reports
News and Reports
Milwaukee Journal Sentinel: Lawmakers must protect, expand Medicare drug cost negotiation
As a patient on Medicare, I rely on my Xarelto prescription to prevent deadly blood clots caused by my rare blood cancer, multiple myeloma and the oral chemotherapy I take daily. These drugs used to cost me anywhere from $15,000 to $21,000 every year for ten years. I’ve had to cobble together grants, decimate my […]
News and Reports
Even so, Merith Basey, the CEO of advocacy organization Patients For Affordable Drugs, expressed concern to Reuters that “Imposing massive tariffs on generic medicines risk making lower-cost generic drugs millions of Americans rely on more expensive and harder to access.”
News and Reports
Asia Times: New Trump tariffs to block Indian, Chinese generic drugs sourcing
Merith Basey, CEO of the advocacy organization Patients for Affordable Drugs, argued that “if the administration intends to lower prescription drug prices, it should not pursue policies that threaten to raise them. Imposing massive tariffs on generic medicines risks making lower-cost generic drugs millions of Americans rely on more expensive and harder to access.” “Generic […]
News and Reports
Benefits and Pensions Monitor: Trump sets 200% tariff cliff for imported generics by 2029
Merith Basey, chief executive of Patients For Affordable Drugs, warned via Reuters that the measure could backfire for patients, saying tariffs “risk making lower-cost generic drugs millions of Americans rely on more expensive and harder to access.”
News and Reports
Merith Basey, CEO of the advocacy organization Patients for Affordable Drugs, argued that “if the administration intends to lower prescription drug prices, it should not pursue policies that threaten to raise them. Imposing massive tariffs on generic medicines risks making lower-cost generic drugs millions of Americans rely on more expensive and harder to access.” “Generic […]
News and Reports
USA Today: Generic drug tariffs set to skyrocket in 2028. Consumers could feel impact
“Imposing massive tariffs on generic medicines risks making lower-cost generic drugs millions of Americans rely on more expensive and harder to access,” said Merith Basey, CEO of Patients for Affordable Drugs. “Tariffs of this magnitude could have enormous consequences − raising costs, worsening shortages and putting access to lifesaving medicines at risk.”